Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors (Q33498657)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors
scientific article

    Statements

    Phase I and pharmacologic study of oral topotecan administered twice daily for 21 days to adult patients with solid tumors (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit